{"id":"CHEMBL1005","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1","inchiKey":"ZTVQQQVZCWLTDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIFENTANIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GI 87084X","IDS-NR-005","Remifentanil","Ultiva"],"crossReferences":{"DailyMed":["remifentanil%20hydrochloride"],"Wikipedia":["Remifentanil"],"drugbank":["DB00899"],"chEBI":["8802"]},"childChemblIds":["CHEMBL1201120"],"count":13,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0000726","EFO_0003777","EFO_0007486","HP_0012735","EFO_1001905","EFO_1000644","EFO_0009267","EFO_0000266","EFO_1000637","MONDO_0024355","EFO_0004253","MONDO_0008903","EFO_0000712","EFO_0005306","EFO_1001062","EFO_0006510","EFO_0003917","EFO_0003877","EFO_0007490","MONDO_0021233","EFO_0000616","EFO_0004799","HP_0001649","HP_0002093","EFO_0001074","HP_0012532","EFO_0002687","EFO_0005323","EFO_0001645","EFO_0010702","EFO_0003843","EFO_0002615","HP_0000713","HP_0001082","EFO_0003890","HP_0002045","EFO_0009842","EFO_1000391","HP_0001336","EFO_0005611","MONDO_0043510","EFO_0003918","EFO_0003833","EFO_0004337","EFO_0005251"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1062","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DBPWSSGDRRHUNT-CEGNMAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYPROGESTERONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17.alpha.-hydroxyprogesterone","Hydroxyprogesterone","NSC-15468","U-3096"],"crossReferences":{"PubChem":["144204784","144211847","170466429","26753584","50106362","56422152","8139906","90340864"],"Wikipedia":["17-Hydroxyprogesterone"],"drugbank":["DB14570"],"chEBI":["17252"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1082723","canonicalSmiles":"C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12","inchiKey":"CKLPLPZSUQEDRT-WPCRTTGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPARGAMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cipargamin","KAE-609","KAE609","Kae609","NITD-609","NITD609"],"crossReferences":{"drugbank":["DB12306"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1120","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBSALICYLATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bismukote","Corrective Suspension","Gastro-Cote","Pepto-Bismol"],"synonyms":["Bismuth subsalicylate"],"crossReferences":{"PubChem":["144205951","225144280","29218057"],"Wikipedia":["Bismuth_subsalicylate"],"chEBI":["261649"]},"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0009130","EFO_0000574","EFO_1000961"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1161998","canonicalSmiles":"O=C(CO)COP(=O)(O)O","inchiKey":"GNGACRATGGDKBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161998","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04326"],"chEBI":["16108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1180074","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"WNBGYVXHFTYOBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRISTALKONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124898794"],"drugbank":["DB13774"]},"childChemblIds":["CHEMBL1473396","CHEMBL2361574","CHEMBL421049","CHEMBL112719"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197118","canonicalSmiles":"CS(=O)(=O)c1ccc2c(c1)nc1n2C[C@H](N)[C@@H](c2cc(F)c(F)cc2F)C1","inchiKey":"HJJAYSSCWGUPKO-ABAIWWIYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1197118","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07193"]},"childChemblIds":["CHEMBL559940"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200613","canonicalSmiles":"Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]","inchiKey":"QGUALMNFRILWRA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLMETIN SODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1020","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tolectin","Tolectin 600","Tolectin ds","Tolmetin sodium"],"synonyms":["MCN-2559-21-98","Tolmetin sodium"],"crossReferences":{"DailyMed":["tolmetin%20sodium"],"PubChem":["26748279"],"chEBI":["9619"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200855","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)[O-])c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]","inchiKey":"ZBBCUBMBMZNEME-QBGWIPKPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"TICARCILLIN DISODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1449","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ticar"],"synonyms":["BRL 2288","BRL-2288","Ticarcillin disodium","Ticarcillin disodium salt","Ticarcillin sodium"],"crossReferences":{"PubChem":["11112962","856016"],"chEBI":["35017"]},"count":3,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for infection and has 2 investigational indications."}
{"id":"CHEMBL1200880","canonicalSmiles":"COS(=O)(=O)[O-].C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1","inchiKey":"BREMLQBSKCSNNH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHEMANIL METHYLSULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201340","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prantal"],"synonyms":["Diphemanil methylsulfate","Diphemanil metilsulfate"],"crossReferences":{"PubChem":["144203900","170464876","56463612"],"Wikipedia":["Diphemanil_metilsulfate"],"chEBI":["59782"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200925","canonicalSmiles":"O=P([O-])(O)O.[K+]","inchiKey":"GNSKLFRGEWLPPA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PHOSPHATE, MONOBASIC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot dihydrogen phos"],"synonyms":["Monobasic potassium phosphate","Potassium phosphate, monobasic"],"crossReferences":{"DailyMed":["potassium%20phosphate,%20monobasic"],"DrugCentral":["4480"],"Wikipedia":["Monopotassium_phosphate"],"drugbank":["DB09413"],"chEBI":["63036"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201010","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"SYWHXTATXSMDSB-GSLJADNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDROCORTISONE ACETATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Astonin","Florinef","Fludrocortisone acetate","Fludrocortone","Panotile"],"synonyms":["Fludrocortisone","Fludrocortisone 21-acetate","Fludrocortisone acetate","Fluorhydrocortisone acetate","NSC-15186"],"crossReferences":{"DailyMed":["fludrocortisone%20acetate"],"chEBI":["5102"]},"count":9,"approvedIndications":["MONDO_0015128","Orphanet_181412"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["Orphanet_64739","MONDO_0015128","MONDO_0002050","EFO_0006834","EFO_0002508","EFO_0000756","EFO_0005252","EFO_1001176","HP_0031273","Orphanet_181412","Orphanet_418"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for adrenogenital syndrome and primary adrenal insufficiency and has 7 investigational indications."}
{"id":"CHEMBL1201407","canonicalSmiles":"CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"TVHAZVBUYQMHBC-SNHXEXRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNOPROSTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Unoprostone"],"crossReferences":{"Wikipedia":["Unoprostone"],"drugbank":["DB06826"],"chEBI":["39455"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201420","drugType":"Enzyme","blackBoxWarning":false,"name":"UROKINASE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbokinase","Kinlytic","Ukidan"],"synonyms":["Urokinase"],"crossReferences":{"DrugCentral":["5109"],"Wikipedia":["Urokinase"]},"count":7,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0009680","EFO_0008585","EFO_0003097","EFO_0000544","EFO_0003827","EFO_0001645","EFO_0000712","EFO_0000612","HP_0004419"],"count":9},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL1201454","drugType":"Small molecule","blackBoxWarning":false,"name":"ALSEROXYLON","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rautensin","Rauwiloid"],"synonyms":["Alseroxylon"],"crossReferences":{"Wikipedia":["Alseroxylon"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201464","drugType":"Protein","blackBoxWarning":false,"name":"CHORIOGONADOTROPIN ALFA","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ovidrel","Ovitrelle"],"synonyms":["ATC CODE G03 GA GONADOTROPINS","Choriogonadotropin alfa","Chorionic gonadotrophin alfa"],"crossReferences":{"DailyMed":["choriogonadotropin%20alfa"],"DrugCentral":["5149"]},"count":3,"approvedIndications":["EFO_0000545"],"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["Orphanet_145","Orphanet_64739","EFO_0000545","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for infertility and has 2 investigational indications."}
{"id":"CHEMBL1201478","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYETHYLENE GLYCOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atpeg 300","Carbowax sentry","Lutrol e","Pluracol e","Polyglycol e 300, e 400, e 1450, e 8000"],"synonyms":["E1521","Polyethylene glycol"],"crossReferences":{"Wikipedia":["Polyethylene_glycol"]},"count":14,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL1201594","drugType":"Enzyme","blackBoxWarning":true,"name":"RASBURICASE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elitek","Fasturtec"],"synonyms":["Rasburicase","SR-29142","SR29142","Urate oxidase"],"crossReferences":{"DailyMed":["rasburicase"],"DrugCentral":["4994"],"Wikipedia":["Rasburicase"]},"count":9,"approvedIndications":["EFO_0004274","EFO_0000574"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for lymphoma and gout and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213351","canonicalSmiles":"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C","inchiKey":"XLMALTXPSGQGBX-GCJKJVERSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPOXYPHENE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2014},"tradeNames":[],"synonyms":["Dextropropoxyphene","Levopropoxyphene","Propoxyphene"],"crossReferences":{"DailyMed":["propoxyphene%20napsylate"],"Wikipedia":["Dextropropoxyphene","Levopropoxyphene"],"drugbank":["DB00647"],"chEBI":["51173"]},"childChemblIds":["CHEMBL3989716","CHEMBL1237104"],"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for pain. It was withdrawn in United States  in 2014 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213553","canonicalSmiles":"CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1","inchiKey":"ISZNZKHCRKXXAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROGUANIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorproguanil","Proguanil hydrochloride related compound f"],"crossReferences":{"drugbank":["DB12314"]},"childChemblIds":["CHEMBL2107534"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1221561","canonicalSmiles":"CN1c2c([nH]c(N)nc2=O)NCC1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"ZNOVTXRBGFNYRX-ABLWVSNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221561","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222035","canonicalSmiles":"CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1Cc2cc(O)ccc2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21","inchiKey":"BVVFOLSZMQVDKV-KXQIQQEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICI-164384","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICI-164384"],"crossReferences":{"drugbank":["DB03860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231277","canonicalSmiles":"O=C(O)[C@@H](Cc1ccc2c(c1)OCO2)[C@H](Cc1ccc2c(c1)OCO2)C(=O)O","inchiKey":"FFYBYVPVYLMLAR-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232313","canonicalSmiles":"C/C(=C/C=C/[C@@H](C)C(=O)O)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O","inchiKey":"VZFRNCSOCOPNDB-AOKDLOFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domoic Acid"],"crossReferences":{"PubChem":["14719311","26751666"],"drugbank":["DB02852"],"chEBI":["34727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233922","canonicalSmiles":"Cc1nc(-c2ccnc(N)n2)cn1Cc1c(Cl)cccc1Cl","inchiKey":"CKSSZTMRRVJNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233922","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08076"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235568","canonicalSmiles":"CS(=O)(=O)Nc1cccc2cccnc12","inchiKey":"XYEPUTZVZYUENX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235568","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["7974518"],"drugbank":["DB08451"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235787","canonicalSmiles":"C[C@H](N)P(=O)(O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"MMWNOZXGYRPSCJ-LZQZEXGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08506"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236661","canonicalSmiles":"Cc1cccc(Cc2nn(C(C)(C)C)c3ncnc(N)c23)c1","inchiKey":"FYCOTGCSHZKHPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236690","canonicalSmiles":"C=CS(=O)(=O)O","inchiKey":"NLVXSWCKKBEXTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINYLSULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124896644"],"drugbank":["DB04359"]},"childChemblIds":["CHEMBL2106422"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12420","canonicalSmiles":"CN(C)CCc1c[nH]c2ccccc12","inchiKey":"DMULVCHRPCFFGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N,N-DIMETHYLTRYPTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N,N-Dimethyltryptamine"],"crossReferences":{"Wikipedia":["Dimethyltryptamine"],"drugbank":["DB01488"],"chEBI":["28969"]},"childChemblIds":["CHEMBL3183055"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125386","canonicalSmiles":"NC(=O)c1cn([C@@H](CO)CCn2ccc3ccc(NC(=O)NCc4ccccc4)cc32)cn1","inchiKey":"KCCUBLLGAMGDJL-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02830"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1282","canonicalSmiles":"CC(C)Cn1cnc2c(N)nc3ccccc3c21","inchiKey":"DOUYETYNHWVLEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIQUIMOD","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldara","Imiquimod","Zyclara"],"synonyms":["Aldara","Imiquimod","R-837","S-26308","S26308"],"crossReferences":{"DailyMed":["imiquimod"],"PubChem":["144204536","170464691","174006731","26752301","865810"],"Wikipedia":["Imiquimod"],"drugbank":["DB00724"],"chEBI":["36704"]},"count":46,"approvedIndications":["EFO_0000763","EFO_0002496"],"linkedTargets":{"rows":["ENSG00000196664"],"count":1},"linkedDiseases":{"rows":["MONDO_0040677","EFO_1002023","EFO_0000756","EFO_1001951","EFO_0007147","EFO_0000565","MONDO_0002974","EFO_0000389","EFO_1000720","EFO_0005046","EFO_0001668","EFO_1000028","EFO_1000166","MONDO_0021054","EFO_0000220","MONDO_0008170","EFO_0002939","EFO_1001968","EFO_0004197","MONDO_0008315","EFO_0002496","EFO_1000026","MONDO_0021639","MONDO_0015917","EFO_0009260","EFO_0001061","EFO_0004192","EFO_0007328","EFO_0003835","EFO_1000172","MONDO_0015686","EFO_0002913","MONDO_0007254","EFO_0002627","EFO_1002048","MONDO_0002158","MONDO_0022394","MONDO_0024474","MONDO_0001657","EFO_0000673","EFO_1001361","EFO_0004212","EFO_0002499","EFO_0004193","EFO_0000707","EFO_1000635","EFO_1000249","MONDO_0021582","MONDO_0005341","EFO_0005222","MONDO_0023619","EFO_0003060","MONDO_0002102","EFO_0000311","Orphanet_624","EFO_0000095","EFO_0000763","MONDO_0024880","EFO_0000519","MONDO_0024475"],"count":60},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for actinic keratosis and viral disease and has 44 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1320667","canonicalSmiles":"O=C(O)CC1CC(c2ccccc2)=NO1","inchiKey":"MUFJHYRCIHHATF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VGX-1027","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VGX-1027","Vgx-1027"],"crossReferences":{"PubChem":["90340977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13280","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21","inchiKey":"PPTYJKAXVCCBDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNITRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," unapproved in United States"],"classes":["Misuse"],"year":1996},"tradeNames":["Rohypnol"],"synonyms":["Flunitrazepam","N05CD03","RO 5-4200","RO-5-4200","RO-54200"],"crossReferences":{"Wikipedia":["Flunitrazepam"],"drugbank":["DB01544"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  unapproved in United States initially in 1996 due to Misuse."}
{"id":"CHEMBL1357","canonicalSmiles":"CC(O)C(=O)[O-].[Na+]","inchiKey":"NGSFWBMYFKHRBD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM LACTATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sod lact co"],"synonyms":["Compound solution of sodium lactate","E-325","E325","INS NO.325","INS-325","NSC-31718","Sodium Lactate","Sodium lactate"],"crossReferences":{"DrugCentral":["4202"],"Wikipedia":["Sodium_lactate"],"chEBI":["75228"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1374843","canonicalSmiles":"N=C(N)NCc1cccc(I)c1.N=C(N)NCc1cccc(I)c1.O=S(=O)(O)O","inchiKey":"XNACDNPGABUBFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1374843","maximumClinicalTrialPhase":0,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204788","144207067","50106455"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13817","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12","inchiKey":"UMUPQWIGCOZEOY-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUTAMOREN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibutamoren","L-163,191","MK-677"],"childChemblIds":["CHEMBL542653","CHEMBL2105872"],"count":1,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["GO_0007568","EFO_0005687"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL13960","canonicalSmiles":"O=C(O)C(Cl)Cl","inchiKey":"JXTHNDFMNIQAHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROACETIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dichloroacetic acid","Dichloroethanoic acid","NSC-2654"],"crossReferences":{"PubChem":["144204684","144209561","144210737","17389935","26753010"],"Wikipedia":["Dichloroacetic_acid"],"drugbank":["DB08809"],"chEBI":["36386"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1400561","canonicalSmiles":"CCC(C(N)=O)N1CCCC1=O","inchiKey":"HPHUVLMMVZITSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etiracetam"],"crossReferences":{"PubChem":["144205826","170464988","29217728"],"drugbank":["DB11868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14173","canonicalSmiles":"Nc1ccccc1C(=O)O","inchiKey":"RWZYAGGXGHYGMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTHRANILIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Benzoic Acid","2-Aminobenzoic Acid","Antranilic Acid"],"crossReferences":{"PubChem":["144204646","144207901","170465552","17390039"],"Wikipedia":["Anthranilic_acid"],"drugbank":["DB04166"],"chEBI":["30754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1465","canonicalSmiles":"CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"DQDAYGNAKTZFIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENPROCOUMON","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Liquamar","Marcoumar"],"synonyms":["BS-7565","Phenprocoumon","Phenprocumone","RO-1-4849"],"crossReferences":{"Wikipedia":["Phenprocoumon"],"drugbank":["DB00946"],"chEBI":["50438"]},"count":4,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000756","EFO_0003907","HP_0004419","HP_0004936"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for recurrent thrombophlebitis and has 3 investigational indications."}
{"id":"CHEMBL151663","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cc3ccccc3o2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)NC1c2ccccc2C[C@H]1O","inchiKey":"AOMZDQMIOCTPQP-CFSTZTOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL151663","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL152632","canonicalSmiles":"O=C1NCCN1c1ncc([N+](=O)[O-])s1","inchiKey":"RDXLYGJSWZYTFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIRIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA 32644","Niridazole"],"crossReferences":{"PubChem":["11112162","144203894","56463576"],"drugbank":["DB13661"],"chEBI":["82349"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1568698","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"PGTVWKLGGCQMBR-FLBATMFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANAXOLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCD 1042","CCD-1042","Ganaxolone"],"crossReferences":{"PubChem":["144205817","170466317","29217560","50111707","90341411"],"drugbank":["DB05087"]},"count":10,"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000102287","ENSG00000022355","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0008526","EFO_0004319","EFO_1000877","EFO_0000474","Orphanet_3451","EFO_0004263","Orphanet_805","EFO_0001358","HP_0001250","Orphanet_908"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1618018","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2","inchiKey":"ZTVIKZXZYLEVOL-MCOXGKPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMATROPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Homatropine"],"crossReferences":{"PubChem":["144206655"],"drugbank":["DB11181"],"chEBI":["5747"]},"childChemblIds":["CHEMBL1319362"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1618340","canonicalSmiles":"C[N+](C)(C)CCOP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O","inchiKey":"RZZPDXZPRHQOCG-OJAKKHQRSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CITICOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citicoline","IP 302","IP-302","NSC-122002"],"crossReferences":{"Wikipedia":["Citicoline"],"chEBI":["49086"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1697708","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"GTGQRSIMEUWHPA-ZBJAFUORSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MEZLOCILLIN SODIUM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1731","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mezlin"],"synonyms":["Mezlocillin sodium","Mezlocillin sodium monohydrate","Mezlocillin sodium salt"],"crossReferences":{"chEBI":["52067"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL1702","canonicalSmiles":"CNCC[C@@H](Oc1ccccc1C)c1ccccc1.Cl","inchiKey":"LUCXVPAZUDVVBT-UNTBIKODSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATOMOXETINE HYDROCHLORIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL641","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atomoxetine hydrochloride","Strattera"],"synonyms":["Atomoxetine hydrochloride","LY-139603","Tomoxetine","Tomoxetine hydrochloride"],"crossReferences":{"DailyMed":["atomoxetine%20hydrochloride"],"PubChem":["144203843","170465067","49681605"],"chEBI":["331697"]},"count":3,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003890","MONDO_0002050","HP_0010865","EFO_0000249","EFO_0004701","EFO_0005230"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for attention deficit hyperactivity disorder and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL170630","canonicalSmiles":"CS(=O)(=O)OCCOS(C)(=O)=O","inchiKey":"QSQFARNGNIZGAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANE DIMETHANE SULFONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethane dimethane sulfonate","Methanesulfonic Acid 2-Methanesulfonyloxy-Ethyl Ester"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1736151","canonicalSmiles":"CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1","inchiKey":"OEGDFSLNGABBKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETAFENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etafenone","Etafenone hydrochloride"],"crossReferences":{"PubChem":["144205399","170466000","29216166"],"drugbank":["DB13845"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743044","drugType":"Antibody","blackBoxWarning":false,"name":"NAMILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MT-203","MT203","Namilumab"],"count":3,"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003898","EFO_0000676"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743079","drugType":"Antibody","blackBoxWarning":false,"name":"TEPROTUMUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tepezza"],"synonyms":["R-1507","RG-1507","RG1507","RO-4858696","RO-4858696-000","RO-4858696000","RO4858696","RO4858696-000","RV-001","RV-001 MONOCLONAL","RV001","RV001 MONOCLONAL","Teprotumumab","Teprotumumab-trbw"],"crossReferences":{"DailyMed":["teprotumumab-trbw"]},"count":5,"approvedIndications":["EFO_1001466"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001466","MONDO_0007254","EFO_0009321","EFO_0000691","EFO_0003060"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for graves ophthalmopathy and has 4 investigational indications."}
{"id":"CHEMBL175198","canonicalSmiles":"CCCCCNC(=O)[C@H](Cc1ccc(OCC(=O)O)c(C(=O)O)c1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)O","inchiKey":"PUAJYWYRZTYQKS-GOTSBHOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175198","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1767164","canonicalSmiles":"O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1","inchiKey":"YANGEESWIGIKOP-UUWRZZSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1004723","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1004723","Gsk-1004723","Gsk1004723"],"crossReferences":{"drugbank":["DB12806"]},"childChemblIds":["CHEMBL3215857","CHEMBL1767170"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL183817","canonicalSmiles":"COC(=O)[C@@H]1C[C@H](C(=O)O)O[C@H]1[C@H](CC(C)C)NC(C)=O","inchiKey":"MUJPWSPVNZGJOW-WRWGMCAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL183817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03257"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1851805","canonicalSmiles":"CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1","inchiKey":"QTGAJCQTLIRCFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPACETAMOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Propacetamol"],"crossReferences":{"PubChem":["170466215"],"drugbank":["DB09288"]},"childChemblIds":["CHEMBL1795480"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1885437","canonicalSmiles":"CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1","inchiKey":"BSHWLCACYCVCJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPRAZINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprazinone","Eprazinone hydrochloride"],"crossReferences":{"PubChem":["50112699"],"drugbank":["DB08990"],"chEBI":["82716"]},"childChemblIds":["CHEMBL2359721"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1957287","canonicalSmiles":"Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1","inchiKey":"XBEQSQDCBSKCHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGOBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-333126","GS-9190","Tegobuvir"],"crossReferences":{"drugbank":["DB11852"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1997223","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1","inchiKey":"YMRFZDHYDKZXPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1997223","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["511307"],"drugbank":["DB09180"],"chEBI":["61099"]},"childChemblIds":["CHEMBL2354465"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028292","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.[K+]","inchiKey":"CTLBXOFGMSQAQY-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2028292","maximumClinicalTrialPhase":0,"parentId":"CHEMBL6","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["551034"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2057236","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)[C@@H]5CCCN5C)cc(F)c4C[C@H]3C[C@@H]12","inchiKey":"IXMIZHVJXGKPJI-HMFHYXQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-271","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tp-271"],"crossReferences":{"drugbank":["DB15040"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103791","canonicalSmiles":"CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12","inchiKey":"UAMAIHOEGLEXSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADIPIPLON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adipiplon","Apiplon","NG2-73"],"crossReferences":{"drugbank":["DB06579"]},"count":1,"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004698"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103851","canonicalSmiles":"S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"FOFDIMHVKGYHRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMUVATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amuvatinib","HPK 56","HPK-56","HPK56","MP 470","MP-470","MP470"],"crossReferences":{"PubChem":["137276002"],"drugbank":["DB12742"]},"childChemblIds":["CHEMBL4071984","CHEMBL4061772","CHEMBL4092757","CHEMBL2105685","CHEMBL4063359","CHEMBL4099995","CHEMBL4085000"],"count":2,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000105976","ENSG00000157404","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104419","canonicalSmiles":"CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c2ccccc2OC)OC)CC1.[Cl-]","inchiKey":"IXRMFSBOHHRXSS-YPMTVOEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOPAFANT","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110618","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minopafant"],"crossReferences":{"PubChem":["144206826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104432","canonicalSmiles":"FCC(F)(F)F","inchiKey":"LVGUZGTVOIAKKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORFLURANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HFA-134-A","Norflurane"],"crossReferences":{"drugbank":["DB13116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104819","canonicalSmiles":"N#CC(c1ccc(F)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl","inchiKey":"XQKYUBTUOHHNDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETRAZURIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letrazuril"],"crossReferences":{"drugbank":["DB12663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106615","canonicalSmiles":"CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12","inchiKey":"OMZAMQFQZMUNTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BAZEDOXIFENE ACETATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL46740","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bazedoxifene acetate","WAY-140424"],"crossReferences":{"DailyMed":["bazedoxifene%20acetate"],"PubChem":["144206564","170466793"]},"count":4,"approvedIndications":["EFO_0003854"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003929","EFO_0003882","EFO_0003922"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for postmenopausal osteoporosis and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106686","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=C(O)CCC(=O)O","inchiKey":"BOONDNCXQPMXQT-SCYNACPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABACAVIR SUCCINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1380","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1592U89","Abacavir succinate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108332","drugType":"Gene","blackBoxWarning":false,"name":"BEPERMINOGENE PERPLASMID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beperminogene perplasmid"],"description":"Gene drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108360","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"MIRAVIRSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Miravirsen","SPC-3649","SPC3649"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108481","drugType":"Unknown","blackBoxWarning":false,"name":"ANCROD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Venacil"],"synonyms":["Ancrod"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108681","drugType":"Antibody","blackBoxWarning":false,"name":"TILDRAKIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilumetri","Ilumya"],"synonyms":["MK-3222","SCH-900222","Tildrakizumab","Tildrakizumab-asmn"],"crossReferences":{"DailyMed":["tildrakizumab-asmn"]},"count":3,"approvedIndications":["EFO_0000676","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000676","EFO_0000540","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for immune system disease and psoriasis and has 1 investigational indication."}
{"id":"CHEMBL2108758","drugType":"Small molecule","blackBoxWarning":false,"name":"PEPPERMINT OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apercap","Colomint","Mintec","Obbekjaers"],"synonyms":["BT MINT 995888","FEMA NO. 2848","Mentha x piperita oil","Peppermint oil","Peppermint volatile oil"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2109027","drugType":"Unknown","blackBoxWarning":false,"name":"BROMELAINS","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ananase"],"synonyms":["Bromelain","Bromelains","Bromelin"],"count":2,"approvedIndications":["HP_0200042"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for skin ulcer and has 1 investigational indication."}
{"id":"CHEMBL2109330","drugType":"Antibody","blackBoxWarning":false,"name":"IC14","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IC-14","IC14","Ic14"],"count":3,"linkedTargets":{"rows":["ENSG00000170458"],"count":1},"linkedDiseases":{"rows":["EFO_0005547","MONDO_0100130","EFO_0000253","EFO_1000637"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109361","drugType":"Antibody","blackBoxWarning":false,"name":"PEMTUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Theragyn"],"synonyms":["Pemtumomab","RG-1549"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109389","drugType":"Antibody","blackBoxWarning":false,"name":"IMGATUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GA-201","GA201","HUMA-B","HUMAB","HuMAB<EGFR>","Imgatuzumab","RG7160","RO-5083945","RO5083945"],"count":4,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000203747"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_0003060","EFO_1001951"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109477","drugType":"Antibody","blackBoxWarning":false,"name":"SELICRELUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD40","CP 870,893","CP-870,893","CP-870893","Cp-870893","RG-7876","RG7876","RO-7009789","Selicrelumab"],"count":6,"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044","EFO_0000096","EFO_0003860","EFO_0000756","MONDO_0007254","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109480","drugType":"Antibody","blackBoxWarning":false,"name":"AHN-12","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AHN-12","Ahn-12"],"count":5,"linkedTargets":{"rows":["ENSG00000081237"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0000339","EFO_0000220","EFO_0000222"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109491","drugType":"Antibody","blackBoxWarning":false,"name":"COL-1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COL-1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109492","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-1411","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1411","Mdx-1411"],"count":1,"linkedTargets":{"rows":["ENSG00000125726"],"count":1},"linkedDiseases":{"rows":["EFO_1001469"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109533","drugType":"Antibody","blackBoxWarning":false,"name":"ORTICUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orticumab","RG-7418"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109534","drugType":"Antibody","blackBoxWarning":false,"name":"PF-03732010","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-03732010","Pf-03732010"],"count":1,"linkedTargets":{"rows":["ENSG00000062038"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109546","drugType":"Antibody","blackBoxWarning":false,"name":"SAR-279356","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F598","SAR-279356","Sar-279356"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109576","drugType":"Antibody","blackBoxWarning":false,"name":"IDEC-159","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IDEC-159"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109625","drugType":"Antibody","blackBoxWarning":false,"name":"MGAWN1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGAWN1","Mgawn1"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110862","canonicalSmiles":"CN(C)CCOCCOC(=O)N1c2ccccc2Sc2ccccc21","inchiKey":"OOVJCSPCMCAXEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHOXANATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethoxanate"],"crossReferences":{"drugbank":["DB13794"]},"childChemblIds":["CHEMBL2106376"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110959","canonicalSmiles":"CC(C)CNCCOC(=O)c1cccc(N)c1","inchiKey":"BXMFKNRZTLNAFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METABUTETHAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metabutethamine"],"crossReferences":{"drugbank":["DB13578"],"chEBI":["81295"]},"childChemblIds":["CHEMBL2106833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212522","canonicalSmiles":"O=C(O)c1cc(Br)ccc1NS(=O)(=O)c1ccc(Cl)cc1","inchiKey":"JDVLYAYDIMUAAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212522","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2151570","canonicalSmiles":"c1cc2cc(-c3ccc(O[C@H]4CN5CCC4CC5)nn3)ccc2[nH]1","inchiKey":"LUKNJAQKVPBDSC-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-107","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-107"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165326","canonicalSmiles":"NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1","inchiKey":"DKULOVKANLVDEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APROCITENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-132577","Act-132577","Aprocitentan"],"crossReferences":{"drugbank":["DB15059"],"chEBI":["76609"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2178578","canonicalSmiles":"CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1","inchiKey":"JRWROCIMSDXGOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERCIRNON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX-282-B","CCX282","GSK-1605786","GSK1605786","Vercirnon","Verecimon"],"crossReferences":{"drugbank":["DB15250"]},"childChemblIds":["CHEMBL3039505"],"count":3,"linkedTargets":{"rows":["ENSG00000173585"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000729","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2219740","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO.[Ca+2]","inchiKey":"YPCRNBPOUVJVMU-LCGAVOCYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLUBIONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neo-calglucon"],"synonyms":["Calcium glubionate"],"crossReferences":{"drugbank":["DB13142"]},"childChemblIds":["CHEMBL2104594"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL222419","canonicalSmiles":"COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC","inchiKey":"UHCHLTQBLNUYRT-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-237701A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK237701A"],"crossReferences":{"drugbank":["DB07471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2373108","canonicalSmiles":"CCCCN(CCCC)C(=S)[S-].CCCCN(CCCC)C(=S)[S-].[Zn+2]","inchiKey":"BOXSVZNGTQTENJ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2373108","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2027996","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206589","144209799"],"drugbank":["DB14194"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2392545","canonicalSmiles":"COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C","inchiKey":"GWRSATNRNFYMDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-960","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-960","TAK960","Tak-960"],"count":1,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL243712","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC","inchiKey":"NTJOBXMMWNYJFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMISULPRIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Amisulpride","DAN-2163"],"crossReferences":{"DailyMed":["amisulpride"],"PubChem":["124891581","144206943","170466480","26719747","26719748","26753203"],"Wikipedia":["Amisulpride"],"drugbank":["DB06288"],"chEBI":["64045"]},"count":11,"approvedIndications":["EFO_0004888","EFO_0005407"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000164270","ENSG00000168830","ENSG00000102468","ENSG00000157219","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000148680","ENSG00000147246","ENSG00000135312","ENSG00000135914","ENSG00000179546","ENSG00000149305","ENSG00000158748","ENSG00000151577","ENSG00000179097","ENSG00000166736"],"count":19},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002050","EFO_0004280","EFO_0006911","MONDO_0002009","HP_0000726","EFO_0004888","EFO_0005407","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0005411","EFO_0004215"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for psychosis and post operative nausea and vomiting and has 9 investigational indications."}
{"id":"CHEMBL256315","canonicalSmiles":"CC(C)(C)CC(=O)O/N=C/c1ccc(O)cc1","inchiKey":"IRHAIEVALGHVLW-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08335"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258728","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)n1","inchiKey":"UOOOPKANIPLQPU-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cytidine 3'-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytidine 3'-Phosphate"],"crossReferences":{"PubChem":["26754279"],"drugbank":["DB01961"],"chEBI":["53013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261720","canonicalSmiles":"Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F","inchiKey":"ARIOBGGRZJITQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261932","canonicalSmiles":"O=C(C[C@H](CSc1ccccc1)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1","inchiKey":"JXAGDPXECXQWBC-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANOMASTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 12-9566","BAY-129566","Tanomastat"],"crossReferences":{"drugbank":["DB06276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262777","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O","inchiKey":"MYPYJXKWCTUITO-LYRMYLQWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VANCOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vancoled","Vancomycin","Vancor"],"crossReferences":{"DailyMed":["vancomycin%20hydrochloride"],"PubChem":["90341222"],"Wikipedia":["Vancomycin"],"drugbank":["DB00512"],"chEBI":["28001"]},"childChemblIds":["CHEMBL1200628"],"count":39,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for bacterial disease and eye infection and has 37 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL272485","canonicalSmiles":"CCCCOC(=O)c1ccccc1C(=O)OCCCC","inchiKey":"DOIRQSBPFJWKBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUTYL PHTHALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibutyl phthalate","Dibutylphthalate"],"crossReferences":{"PubChem":["144208927","144211297","17389633","26747249","56462803"],"drugbank":["DB13716"],"chEBI":["34687"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL275339","canonicalSmiles":"Oc1ccc(-n2ccnc2)cc1","inchiKey":"CYKCUAPYWQDIKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL275339","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08214"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284104","canonicalSmiles":"O=C(O)c1cccc(C(=O)O)n1","inchiKey":"WJJMNDUMQPNECX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPICOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dipicolinic Acid"],"crossReferences":{"PubChem":["144211446","863941"],"Wikipedia":["Dipicolinic_acid"],"drugbank":["DB04267"],"chEBI":["46837"]},"childChemblIds":["CHEMBL4521011","CHEMBL177801"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28564","canonicalSmiles":"OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1","inchiKey":"GGUSQTSTQSHJAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIPRODIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eliprodil"],"crossReferences":{"PubChem":["144204745","170466155","26753224","26753225","26753226","90340808"],"Wikipedia":["Eliprodil"],"drugbank":["DB12869"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL295619","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1","inchiKey":"NJCJBUHJQLFDSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MF 934","Rufloxacin"],"crossReferences":{"PubChem":["26719881","49681571","50105208"],"Wikipedia":["Rufloxacin"],"drugbank":["DB13772"],"chEBI":["8909"]},"childChemblIds":["CHEMBL1385206"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039539","drugType":"Antibody","blackBoxWarning":false,"name":"OTLERTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Otlertuzumab","TRU-016"],"count":1,"linkedTargets":{"rows":["ENSG00000104894"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039588","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O","inchiKey":"NEEFMPSSNFRRNC-PPCPDXGKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE DIASPARTATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor"],"synonyms":["Pasireotide diaspartate"],"crossReferences":{"DailyMed":["pasireotide%20diaspartate"]},"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":4},"linkedDiseases":{"rows":["EFO_1001485"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2012."}
{"id":"CHEMBL3113734","canonicalSmiles":"Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3ccc(F)c(F)c3)CC2)c1","inchiKey":"OHIUQAZROSYCMC-CALCHBBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UK-500001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uk-500001"],"crossReferences":{"drugbank":["DB12837"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3126832","canonicalSmiles":"CC(C)[C@H]1NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C)C(=O)N2)OC(=O)C[C@@H]1O","inchiKey":"XFLBOEMFLGLWFF-HDXRNPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBP-801","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obp-801","YM-753"],"crossReferences":{"drugbank":["DB12279"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3219124","canonicalSmiles":"COC[C@H](C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)Nc2cnc(C)cn2)c1","inchiKey":"FJEJHJINOKKDCW-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1656","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1656","Azd 1656","Azd-1656","Azd1656"],"crossReferences":{"drugbank":["DB14810"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3249801","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"FVLRMKYACTYDNC-JBQXJEBLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3249801","maximumClinicalTrialPhase":0,"parentId":"CHEMBL592","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329363","canonicalSmiles":"CCN(CC)S(=O)(=O)c1ccc(Cl)c(C(=O)Nc2sc3c(c2C#N)CCC3)c1","inchiKey":"MZCDQILVXXIMEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329363","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3393588","canonicalSmiles":"O=C(c1cccnc1)N1CCN2C(=O)c3ccncc3[C@]12c1ccc(Cl)cc1","inchiKey":"QZSZPSDRJPPZDZ-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BTA-9881","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9639","BTA9881","Bta-9881","Bta9881","MEDI-564","Medi 564"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3402762","canonicalSmiles":"CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1","inchiKey":"AHYMHWXQRWRBKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 1214063","EMD-1214063","EMD1214063","Emd-1214063","MSC-2156119","MSC-2156119J","MSC2156119","Tepotinib"],"crossReferences":{"drugbank":["DB15133"]},"childChemblIds":["CHEMBL4594292"],"count":3,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000182","EFO_0001421","EFO_0004142","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL342466","canonicalSmiles":"[2H]C([2H])(CCl)NP1(=O)OCCCN1C([2H])([2H])CCl","inchiKey":"HOMGKSMUEGBAAB-WVTKESLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL342466","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1024","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL343892","canonicalSmiles":"COC(=O)C1CCN(C(=O)[C@H](Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1","inchiKey":"JJLGQWCKMHPBEB-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL343892","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3526399","canonicalSmiles":"CCNC1(C(N)=O)CCN(c2ncnc3c2n[14c](-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1.Cl","inchiKey":"KPYUQCJBZGQHPL-YYTSLCBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3526399","maximumClinicalTrialPhase":0,"parentId":"CHEMBL562668","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544955","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY-1217389","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-1217389","Bay-1217389"],"count":1,"linkedTargets":{"rows":["ENSG00000112742"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544995","drugType":"Cell","blackBoxWarning":false,"name":"STAPULDENCEL-T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DCVAC/PCa","Stapuldencel-t"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545000","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2201","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-2201"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545087","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK159802","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk159802"],"count":1,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545150","drugType":"Small molecule","blackBoxWarning":false,"name":"AZM-475271","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azm-475271"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545169","canonicalSmiles":"CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2","inchiKey":"BLLNYXOLLAVTRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1305","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 1305","Azd1305"],"count":2,"linkedTargets":{"rows":["ENSG00000183873","ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000055118","ENSG00000102001"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545179","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-7451","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd-7451"],"count":1,"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000519"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545300","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-459632","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cp-459632"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545309","canonicalSmiles":"C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.CC(=O)O","inchiKey":"WSMXIQXWHPSVDE-ZPJPNJFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEFAMULIN ACETATE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3291398","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xenleta"],"synonyms":["BC-3781.Ac","Lefamulin acetate"],"crossReferences":{"DailyMed":["lefamulin%20acetate"]},"count":1,"approvedIndications":["EFO_1001272"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for bacterial pneumonia."}
{"id":"CHEMBL3545346","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2516","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd2516"],"count":1,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545378","canonicalSmiles":"Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1","inchiKey":"SLUHYAXFRJQTGB-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-6592","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-6592","VX-667"],"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545395","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-811283","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi-811283"],"count":2,"linkedTargets":{"rows":["ENSG00000178999"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL355200","canonicalSmiles":"C#Cc1cnc(O)nc1O","inchiKey":"JOZGNYDSEBIJDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENILURACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["776-C-85","776C85","Eniluracil"],"crossReferences":{"drugbank":["DB03516"]},"count":7,"linkedTargets":{"rows":["ENSG00000188641"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000365","MONDO_0007254","EFO_0000574","EFO_1000657","MONDO_0021063","EFO_1001951"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL356479","canonicalSmiles":"CCCCC(CC)C1NC(=O)N(SC(Cl)(Cl)Cl)C1=O","inchiKey":"VOGJJBHRUDVEFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORDANTOIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlordantoin","Clodantoin"],"crossReferences":{"drugbank":["DB13516"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3644587","canonicalSmiles":"O=c1[nH]nc2[nH]c(CN3Cc4ccccc4C3)nc3cccc1c32","inchiKey":"JLFSBHQQXIAQEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2X-121","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2X-121","2x-121","E-7449","E7449"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3655081","canonicalSmiles":"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1","inchiKey":"IUEWXNHSKRWHDY-PHIMTYICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABROCITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abrocitinib","PF-04965842","Pf-04965842"],"crossReferences":{"drugbank":["DB14973"]},"count":4,"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","EFO_0000676","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707225","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2798745","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2798745"],"count":5,"linkedTargets":{"rows":["ENSG00000111199"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","HP_0012735","EFO_0003144","EFO_1001134","EFO_0000373"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707333","canonicalSmiles":"O[B-]1(O)OO[B-](O)(O)OO1.[Na+].[Na+]","inchiKey":"JBUKJLNBQDQXLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PERBORATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707334","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bocasan"],"synonyms":["Sodium perborate"],"crossReferences":{"DrugCentral":["4777"]},"count":1,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL37676","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2","inchiKey":"SEBPXHSZHLFWRL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APC-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APC-100","Apc-100","NSC-226236"],"crossReferences":{"drugbank":["DB13111"]},"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL385937","canonicalSmiles":"Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N)ncc2c1","inchiKey":"YEIASMOUYNOXGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06925"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3975791","canonicalSmiles":"[2H]C([2H])([2H])Oc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1","inchiKey":"OLAHOMJCDNXHFI-GKOSEXJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3975791","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989506","canonicalSmiles":"CN(C)CCOCC(=O)NC12CC3CC(CC(C3)C1)C2","inchiKey":"UXQDWARBDDDTKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROMANTADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tromantadine"],"crossReferences":{"drugbank":["DB13288"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989640","canonicalSmiles":"O.O.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Mg+2]","inchiKey":"HJWFTNWQKDPLAS-SYAJEJNSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM GLUCONATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107145","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Almora"],"synonyms":["Magnesium gluconate"],"crossReferences":{"drugbank":["DB13749"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989698","canonicalSmiles":"N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1.O=S(=O)(O)O","inchiKey":"BKPRVQDIOGQWTG-ICOOEGOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANYLCYPROMINE SULFATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989843","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pamate","Parnate","Parstelin","Tranylcypromine sulfate"],"synonyms":["Tranylcypromine sulfate"],"crossReferences":{"DailyMed":["tranylcypromine%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989855","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1.CN[C@@H](C)[C@@H](O)c1ccccc1.O=S(=O)(O)O","inchiKey":"CAVQBDOACNULDN-NRCOEFLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE SULFATE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrinol"],"synonyms":["Pseudoephedrine sulfate","SCH 4855","SCH-4855"],"crossReferences":{"DailyMed":["pseudoephedrine%20sulfate"]},"count":2,"approvedIndications":["EFO_0005854","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003956"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for allergic rhinitis and seasonal allergic rhinitis."}
{"id":"CHEMBL3989947","canonicalSmiles":"CCCCCCCCCCCCCCOc1ccc(C(=O)OCC(=O)N(C)CC(=O)OCC)o1","inchiKey":"FYJLDICZGDFWKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLUMACOSTAT GLASARETIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DRM-01B","DRM01B","DRMO1B","Olumacostat glasaretil"],"crossReferences":{"drugbank":["DB12642"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3990042","drugType":"Antibody","blackBoxWarning":false,"name":"GOSURANEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB092","BMS-986168","BMS-986168-01","Gosuranemab","IPN-007"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4069597","canonicalSmiles":"Cc1nc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)sc1S(N)(=O)=O","inchiKey":"IVZKZONQVYTCKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRITELIVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AIC-316","AIC316","Aic316","Pritelivir"],"crossReferences":{"drugbank":["DB11844"]},"childChemblIds":["CHEMBL4562772","CHEMBL4082238"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4076467","canonicalSmiles":"COc1c(/C=C/c2ccc(NS(C)(=O)=O)cc2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C","inchiKey":"XMZSTQYSBYEENY-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-072","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-072","Abt-072"],"crossReferences":{"drugbank":["DB15156"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL414804","drugType":"Small molecule","blackBoxWarning":true,"name":"OXALIPLATIN","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eloxatin","Oxaliplatin"],"synonyms":["JM-83","L-OHP","MBP-426 (LIPOSOMAL OXALIPLATIN)","NSC-266046","Oxaliplatin","RP-54780","SR-96669"],"crossReferences":{"DailyMed":["oxaliplatin"],"DrugCentral":["4210"],"PubChem":["144206138","144206182"],"Wikipedia":["Oxaliplatin"]},"childChemblIds":["CHEMBL1983570"],"count":88,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for neoplasm and cancer and has 86 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL416956","canonicalSmiles":"OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1","inchiKey":"XEEQGYMUWCZPDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEFLOQUINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GNF-Pf-5544","Lariam","Mefaquin","Mefloquine","RO 21-5998","RO-215998","WR 142,490"],"crossReferences":{"DailyMed":["mefloquine%20hydrochloride"],"PubChem":["174006936","26748684","29216385"],"Wikipedia":["Mefloquine"],"drugbank":["DB00358"],"chEBI":["63681"]},"childChemblIds":["CHEMBL535650"],"count":7,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for malaria and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL424","canonicalSmiles":"O=C(O)c1ccccc1O","inchiKey":"YGSDEFSMJLZEOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALICYLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acnisal","Advanced pain relief callus removers","Advanced pain relief com removers","Bazuka","Clear away wart remover","Compound v","Compound w","Cuplex verruca","Dr. scholl's callus removers","Dr. scholl's corn removers","Dr. scholl's wart remover kit","Duofilm","Duofilm wart remover","Duoplant","Edinburgh","Erytex","Freezone","Gppe paint","Ionil","Ionil-plus","Jadit","Keralyt","Metanium","Necol","Noxacorn","Occlusal","Phiso-clear","Phytex","Phytocil","Posalfilin","Pyralvex","Salactol","Salatac","Salicylic acid soap","Saligel","Stri-dex","Thwart","Toepedo","Verrugon","Wartex"],"synonyms":["2-Hydroxy-benzoic acid","FEMA NO. 3985","K-557","Lamivudine impurity, salicylic acid-","Lamivudine related compound salicylic acid","NSC-180","Salicylic Acid","Salicylic acid","Salicylic acid rs"],"crossReferences":{"PubChem":["124893592","144207002","144208669","144213426","29215390","8139912"],"Wikipedia":["Salicylic_acid"],"drugbank":["DB00936"],"chEBI":["16914"]},"childChemblIds":["CHEMBL3137698"],"count":18,"approvedIndications":["EFO_0003894","EFO_0005752"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye inflammation and acne and has 16 investigational indications."}
{"id":"CHEMBL4286909","canonicalSmiles":"CCCCOc1cccc(CCNCC(=O)N(C)C)c1.Cl","inchiKey":"DXNSJWVLSBMXNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4286909","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3678076","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4296719","canonicalSmiles":"O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O","inchiKey":"DVJAMEIQRSHVKC-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUTOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dutogliptin","PHX1149","Phx1149"],"crossReferences":{"drugbank":["DB11723"]},"childChemblIds":["CHEMBL4297203"],"count":1,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297277","canonicalSmiles":"CC(/C=C1\\SC(=S)N(CC(=O)O)C1=O)=C\\c1ccccc1.CC(/C=C1\\SC(=S)N(CC(=O)[O-])C1=O)=C\\c1ccccc1.C[N+](C)(C)CCO","inchiKey":"WKSNHZZSMLFYFI-UROVXFGGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIEPALRESTAT CHOLINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL56337","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diepalrestat choline"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297405","canonicalSmiles":"NS(=O)(=O)OC[C@H]1C[C@@H](Nc2ccnc3cc(-c4cccc(SC(F)(F)F)c4)nn23)[C@H](O)[C@@H]1O","inchiKey":"KJDAGXLMHXUAGV-DGWLBADLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-243","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN-7243","MLN7243","Mln7243","Tak-243"],"crossReferences":{"drugbank":["DB15013"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297531","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2ccc(NC(N)=O)cc2)NC(=O)[C@H](Cc2ccc(NC(=O)[C@@H]3CC(=O)NC(=O)N3)cc2)NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CSSC[C@@H](C(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)NC1=O","inchiKey":"ZJZDXGQUNVNYQP-MXEXKMKYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SATOREOTIDE TETRAXETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DOTA-JR-11","Satoreotide tetraxetan"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297553","drugType":"Protein","blackBoxWarning":false,"name":"VALANAFUSP ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGT-181","Agt-181","Valanafusp alfa"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297583","canonicalSmiles":"Cc1nc2cc(C(=O)N(C)C)cc(O[C@H]3CCOc4cc(F)cc(F)c43)c2[nH]1","inchiKey":"CLIQCDHNPDMGSL-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGOPRAZAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LXI-15028","Lxi-15028","Tegoprazan"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297711","drugType":"Protein","blackBoxWarning":false,"name":"BULEVIRTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bulevirtide"],"count":1,"linkedTargets":{"rows":["ENSG00000100652"],"count":1},"linkedDiseases":{"rows":["EFO_0007304"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297779","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"LUMASIRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-65585","ALN-65585","ALN-G01","ALN-GO1","Lumasiran"],"count":1,"linkedTargets":{"rows":["ENSG00000101323"],"count":1},"linkedDiseases":{"rows":["Orphanet_416","Orphanet_93598"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297784","drugType":"Unknown","blackBoxWarning":false,"name":"MK-4280","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-4280","Mavezelimab","Mk-4280"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297804","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06263507","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-06263507"],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297949","drugType":"Protein","blackBoxWarning":false,"name":"AVEXITIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avexitide","Exendin (9-39)","Exendin 9-39","Exendin(9-39)amide"],"count":5,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297950","drugType":"Protein","blackBoxWarning":false,"name":"BENEGRASTIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benegrastim","Efbemalenograstim alfa","F-627"],"count":2,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298092","drugType":"Antibody","blackBoxWarning":false,"name":"GLOFITAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glofitamab","RG-6026","RG6026","RO-7082859","RO7082859","Ro-7082859","Ro7082859"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298103","drugType":"Unknown","blackBoxWarning":false,"name":"CINHYALURONATE SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinhyaluronate sodium","SI-614","SODIUM SALT OF HYALURONIC ACID PARTLY (12%) AMIDIFIED WITH 3-((3-PHENYLPROP-2-ENOYL)OXY)PROPAN-1-AMINE","Si-614"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298106","drugType":"Unknown","blackBoxWarning":false,"name":"MONTMORILLONITE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diosmectite","Montmorillonite","Smecta"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298111","drugType":"Unknown","blackBoxWarning":false,"name":"APILIMOD MESYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apilimod mesylate","STA 5326 MESYLATE","STA-5326 MESYLATE","Sta 5326 mesylate","Sta-5326 mesylate"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298138","canonicalSmiles":"C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1","inchiKey":"FIKPXCOQUIZNHB-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPOTRECTINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Repotrectinib","TPX-0005","TRX-0005"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4474565","canonicalSmiles":"[2H]C([2H])([2H])C([2H])([2H])N1C([2H])([2H])C([2H])([2H])N(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)C([2H])([2H])C1([2H])[2H]","inchiKey":"UZWDCWONPYILKI-ZBLYSMHISA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4474565","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301610","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4518483","canonicalSmiles":"N#Cc1ccc(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)n2)c(F)c1","inchiKey":"HYBAKUMPISVZQP-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06882961","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06882961","Pf-06882961"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL457077","canonicalSmiles":"O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O","inchiKey":"YMGFTDKNIWPMGF-UCPJVGPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALVIANOLIC ACID A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Salvianolic acid a"],"crossReferences":{"drugbank":["DB15246"],"chEBI":["9017"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4576729","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)(O)O.[Na+].[Na+].[Na+].[Na+]","inchiKey":"WLWZPMBKWDHCLU-VKZMHLLXSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4576729","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594356","drugType":"Unknown","blackBoxWarning":false,"name":"DS-8273A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-8273","DS-8273A","Ds-8273a"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594443","canonicalSmiles":"C[C@@H](NC(=O)C(C)(F)F)[C@@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2","inchiKey":"ZZWJKLGCDHYVMB-XGBAOLAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELSECORAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-7594","AZD7594","Azd 7594","Azd7594","Velsecorat"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594480","drugType":"Unknown","blackBoxWarning":false,"name":"L-DOS47","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-dos47"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594509","drugType":"Unknown","blackBoxWarning":false,"name":"TT-00420","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TT-00420","Tt-00420"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL469117","canonicalSmiles":"Cc1ccc(Nc2cc(-c3ccccc3)ncn2)cc1NS(C)(=O)=O","inchiKey":"CXQRKICWSCAUGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL469117","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07175"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL476","canonicalSmiles":"CN(C)/N=N/c1[nH]cnc1C(N)=O","inchiKey":"FDKXTQMXEQVLRF-ZHACJKMWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACARBAZINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dacarbazine","Dtic-dome"],"synonyms":["DIC","DTIC","Dacarbazine","NCI C04717","NSC-45388"],"crossReferences":{"DailyMed":["dacarbazine"],"PubChem":["17389952","26747399","99125"],"Wikipedia":["Dacarbazine"],"drugbank":["DB00851"]},"count":22,"approvedIndications":["MONDO_0009348","EFO_0000616","EFO_0000756","EFO_0000389","EFO_0000183","EFO_0002617","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 7 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL486146","canonicalSmiles":"O=C(O)C(=O)N[C@H](Cc1ccccc1)C(=O)O","inchiKey":"ULQWGBCNOHBNDB-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL486146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08263"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49080","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1","inchiKey":"STJMRWALKKWQGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLENBUTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spiropent","Spiropent mite"],"synonyms":["Clenbuterol","Clenbuterol hydrochloride","NAB 365"],"crossReferences":{"PubChem":["144205569","170465955","26756514","29216418"],"Wikipedia":["Clenbuterol"],"drugbank":["DB01407"],"chEBI":["174690"]},"childChemblIds":["CHEMBL1330729"],"count":3,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","Orphanet_365","EFO_0000253"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for airway obstruction and has 2 investigational indications."}
{"id":"CHEMBL496311","canonicalSmiles":"Cl.O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1","inchiKey":"NHFNYIVVGIXBPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL496311","maximumClinicalTrialPhase":0,"parentId":"CHEMBL495727","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506","canonicalSmiles":"COc1cc(NC(C)CCCN)c2ncccc2c1","inchiKey":"INDBQLZJXZLFIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PRIMAQUINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-27296","Primaquine","SN-13272","WR-2975"],"crossReferences":{"DailyMed":["primaquine%20phosphate"],"PubChem":["174006623","24715072","24715073","50123426"],"Wikipedia":["Primaquine"],"drugbank":["DB01087"],"chEBI":["8405"]},"childChemblIds":["CHEMBL3217110","CHEMBL994","CHEMBL43128"],"count":6,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for malaria and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL506247","canonicalSmiles":"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1","inchiKey":"LRBQNJMCXXYXIU-PPKXGCFTSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"TANNIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E181","FEMA NO. 3042","NSC-656273","Tannic acid"],"crossReferences":{"DrugCentral":["5039"],"PubChem":["124896727","144204975","144210399","57260395"],"TG-GATEs":["93"],"Wikipedia":["Tannic_acid"],"chEBI":["81066"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL511","canonicalSmiles":"COc1ccc(CN(CCN(C)C)c2ccccn2)cc1","inchiKey":"YECBIJXISLIIDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRILAMINE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mepyramine","Pyrilamine"],"crossReferences":{"PubChem":["104171213","11111639","11111640","11113355","144203781","144208176","170464656","17389532","26751558","50100317","50104164","90341279"],"Wikipedia":["Mepyramine"],"drugbank":["DB06691"],"chEBI":["6762"]},"childChemblIds":["CHEMBL1201006"],"count":2,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0003785"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for allergy and pruritus."}
{"id":"CHEMBL517231","canonicalSmiles":"C#C[C@]1(CO)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O","inchiKey":"IKKXOSBHLYMWAE-QRPMWFLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISLATRAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Islatravir","MK-8591","Mk-8591"],"crossReferences":{"drugbank":["DB15653"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL537669","canonicalSmiles":"COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21.Cl","inchiKey":"PIPZGJSEDRMUAW-VJDCAHTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"YOHIMBINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL15245","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prowess plain","Yocon"],"synonyms":["NSC-19509","Yohimbine hydrochloride"],"crossReferences":{"PubChem":["50085982","50107142"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL554","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1","inchiKey":"BCFGMOOMADDAQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAPATINIB","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tyverb"],"synonyms":["GSK-572016","GW-2016","GW-572016","GW-572016X","GW572016","Lapatinib"],"crossReferences":{"DailyMed":["lapatinib%20ditosylate"],"PubChem":["103905567","103905568","144206058","170465125","50100107"],"Wikipedia":["Lapatinib"],"drugbank":["DB01259"],"chEBI":["49603"]},"childChemblIds":["CHEMBL1201179","CHEMBL3526325","CHEMBL1076241","CHEMBL1201183"],"count":33,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000292","EFO_0000365","EFO_0002938","EFO_0000756","EFO_0000681","EFO_1001465","MONDO_0007254","EFO_0005950","MONDO_0002087","EFO_0000228","EFO_0000305","MONDO_0020654","EFO_1001951","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_0006352","MONDO_0002974","EFO_0003884","MONDO_0001657","EFO_0000326","EFO_0000707","EFO_1000158","EFO_0000616","EFO_0002618","EFO_0006859","EFO_0005922","EFO_0006318","EFO_0005774","MONDO_0008170","EFO_1001512","MONDO_0007576","EFO_1001968","EFO_0000504","EFO_0000402","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_1001967","MONDO_0044787","EFO_1000478","EFO_0006861","EFO_0002892","MONDO_0011962","EFO_0000574","MONDO_0024880","EFO_0000519","EFO_0000181","MONDO_0044926"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for neoplasm and cancer and has 31 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL556262","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12","inchiKey":"HGGAKXAHAYOLDJ-FHZUQPTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAROPENEM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Faropenem"],"crossReferences":{"PubChem":["144205728","170466271"],"Wikipedia":["Faropenem"],"drugbank":["DB12190"],"chEBI":["51257"]},"childChemblIds":["CHEMBL431753"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL559358","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.Cl","inchiKey":"BSJUIBZAXCXFMZ-NATPOTRJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL559358","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1639","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207141","170465199"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21","inchiKey":"ZEKZLJVOYLTDKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMEFLOXACIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Okacyn"],"synonyms":["Lomefloxacin","Maxaquin","SC-47111A"],"crossReferences":{"PubChem":["174007186","90340951"],"Wikipedia":["Lomefloxacin"],"drugbank":["DB00978"],"chEBI":["116278"]},"childChemblIds":["CHEMBL2106827","CHEMBL3765217","CHEMBL1728"],"count":3,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for bacterial disease and eye infection and has 1 investigational indication."}
{"id":"CHEMBL561660","canonicalSmiles":"NC(=O)c1cnc2ccn(S(=O)(=O)c3ccccc3[N+](=O)[O-])c2c1","inchiKey":"USLOIFPDNUDIEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572284","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO","inchiKey":"IXWNTLSTOZFSCM-YVACAVLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMBRABULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC7700","AVE-8062","AVE8062","Ave8062","Ombrabulin"],"crossReferences":{"drugbank":["DB12882"]},"childChemblIds":["CHEMBL585539"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL576127","canonicalSmiles":"O=C1NCC2(CCN(CCc3ccccc3)CC2)O1","inchiKey":"FVNFBBAOMBJTST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENSPIRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenspiride"],"crossReferences":{"PubChem":["11111183","11112904","90341038"],"Wikipedia":["Fenspiride"],"drugbank":["DB08979"]},"childChemblIds":["CHEMBL1256849"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL625","canonicalSmiles":"c1ccc2[nH]c(-c3cscn3)nc2c1","inchiKey":"WJCNZQLZVWNLKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIABENDAZOLE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Equizole","Mintezol","Omnizole","Tiabendazole"],"synonyms":["E233","MK-360","Thiabendazole","Tiabendazole"],"crossReferences":{"PubChem":["104171300","11112304","124882215","124882217","144203978","144209595","144211287","170464939","17389714","174006224","26746923","26751457","397296","4262837","481912"],"Wikipedia":["Tiabendazole"],"drugbank":["DB00730"],"chEBI":["45979"]},"count":1,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967 and is indicated for helminthiasis."}
{"id":"CHEMBL66693","canonicalSmiles":"C[C@@H](N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-ALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Alanine"],"crossReferences":{"PubChem":["11113403","144204454","170465038","26751643"],"Wikipedia":["Alanine"],"drugbank":["DB01786"],"chEBI":["15570"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL70246","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O","inchiKey":"HCYFGRCYSCXKNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEFYLLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466658"],"Wikipedia":["Acefylline"],"drugbank":["DB13573"]},"childChemblIds":["CHEMBL2106660"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL714","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1","inchiKey":"NDAUXUAQIAJITI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALBUTEROL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerolin","Aerolin 400","Aerolin auto","Airomir","Airsalb","Albuterol","Asmasal clickhaler","Asmasal spacehaler","Asmaven","Asmavent","Cobutolin","Combivent","Combivent udvs","Ipramol steri-neb","Kentamol","Libetist","Maxivent","Proair Hfa","Proventil","Proventil Hfa","Rimasal","Salamol e-breathe","Salapin","Salbulin novolizer","Salbuvent","Salipraneb","Steri-neb salamol","Ventmax sr","Ventodisks","Ventolin","Ventolin Hfa","Ventolin cr","Ventolin e-breathe","Volmax"],"synonyms":["Accuneb","Albuterol","Combivent","Duoneb","PROVENTIL-HFA","SCH 13949W","SCH-13949W","Salbutamol","Volmax"],"crossReferences":{"DailyMed":["albuterol","albuterol%20sulfate"],"PubChem":["104171238","144203817","170465034","50104505","90340718","90341530"],"Wikipedia":["Salbutamol"],"drugbank":["DB01001"],"chEBI":["2549"]},"childChemblIds":["CHEMBL1437301","CHEMBL1201026","CHEMBL1441059"],"count":25,"approvedIndications":["HP_0006536","EFO_0000270","EFO_0000341","HP_0025428"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0100130","HP_0012735","MONDO_0002009","HP_0002153","EFO_0000768","EFO_1001919","EFO_0010638","EFO_0000373","Orphanet_538","EFO_0009715","HP_0011950","EFO_0009836","Orphanet_365","Orphanet_1764","EFO_1001134","EFO_0010581","EFO_0000400","EFO_0009686","MONDO_0005149","Orphanet_275766","EFO_0008590","Orphanet_590","EFO_0000319","EFO_0003818","MONDO_0004784","HP_0006536","EFO_0001072","MONDO_0001208","EFO_0000270","Orphanet_1480","EFO_0000341","HP_0025428","EFO_0003956","EFO_0003785"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL72","canonicalSmiles":"CNCCCN1c2ccccc2CCc2ccccc21","inchiKey":"HCYAFALTSJYZDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESIPRAMINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desipramine"],"crossReferences":{"DailyMed":["desipramine%20hydrochloride"],"PubChem":["11111066","11111067","174316136","50100220","50104283","90341801"],"Wikipedia":["Desipramine"],"drugbank":["DB01151"],"chEBI":["47781"]},"childChemblIds":["CHEMBL227644","CHEMBL1696"],"count":11,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","HP_0012532","MONDO_0002009","EFO_0004234","EFO_0001358","HP_0003418","Orphanet_778","HP_0011868","EFO_0003829","EFO_0000311","EFO_0003948","EFO_0003890","MONDO_0002050","Orphanet_35069","EFO_0000702","EFO_0003761","EFO_0003918"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for unipolar depression and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL766","canonicalSmiles":"CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)O","inchiKey":"DHSUYTOATWAVLW-WFVMDLQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILASTATIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cilastatin","Primaxin"],"crossReferences":{"DailyMed":["cilastatin%20sodium"],"PubChem":["50125939"],"Wikipedia":["Cilastatin"],"drugbank":["DB01597"],"chEBI":["3697"]},"childChemblIds":["CHEMBL1201057"],"count":7,"linkedTargets":{"rows":["ENSG00000015413"],"count":1},"linkedDiseases":{"rows":["EFO_0003106","HP_0100806","EFO_0003103","EFO_0000771","EFO_1001865","EFO_0000544","EFO_1001141","EFO_0003102","EFO_1001272","EFO_0000465"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 7 investigational indications."}
{"id":"CHEMBL773","canonicalSmiles":"NCC(=O)O","inchiKey":"DHMQDGOQFOQNFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycolixir"],"synonyms":["Aminoacetic acid","FEMA NO. 3287","Glycine","Glycocoll","NSC-25936"],"crossReferences":{"PubChem":["11113413","144207124","170466831"],"Wikipedia":["Glycine"],"drugbank":["DB00145"],"chEBI":["15428"]},"childChemblIds":["CHEMBL3707233"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL777","canonicalSmiles":"O=C(O)[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21","inchiKey":"HZZVJAQRINQKSD-PBFISZAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAVULANIC ACID","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL 14151","BRL-14151","Clavulanate","Clavulanic Acid","Clavulanic acid","RX-10100"],"crossReferences":{"DailyMed":["clavulanate%20potassium"],"Wikipedia":["Clavulanic_acid"],"drugbank":["DB00766"],"chEBI":["48947"]},"childChemblIds":["CHEMBL9306","CHEMBL8290","CHEMBL1003"],"count":26,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 26 investigational indications."}
{"id":"CHEMBL83116","canonicalSmiles":"Oc1c(Cl)cc(-c2cc(Cl)c(O)c(Cl)c2)cc1Cl","inchiKey":"YCYDXOVJXVALHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL83116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03346"],"chEBI":["35434"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL885","canonicalSmiles":"Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F","inchiKey":"XQSPYNMVSIKCOC-NTSWFWBYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EMTRICITABINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emtriva"],"synonyms":["(-)-FTC","524-W-91","524W91","BW-524W91","Emtricitabine","Emtriva","FTC","FTC-(-)"],"crossReferences":{"DailyMed":["emtricitabine"],"PubChem":["144205746"],"Wikipedia":["Emtricitabine"],"drugbank":["DB00879"],"chEBI":["31536"]},"count":10,"approvedIndications":["EFO_0000764","EFO_0000180","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL926","canonicalSmiles":"CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1","inchiKey":"JRWZLRBJNMZMFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOBUTAMINE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 81929","COMPOUND-81929","Dobutamine","Dobutrex"],"crossReferences":{"PubChem":["104171143","144203677","170465050","26751752","50104446","90341592"],"Wikipedia":["Dobutamine"],"drugbank":["DB00841"],"chEBI":["4670"]},"childChemblIds":["CHEMBL1200418","CHEMBL4297079"],"count":6,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0004610","HP_0100806","EFO_0007372","EFO_0006834","EFO_0003144","EFO_0000319","MONDO_0043510","HP_0031273","EFO_0005251"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for cardiovascular disease and has 5 investigational indications."}
{"id":"CHEMBL9298","canonicalSmiles":"N#Cc1ccc(C2CCCc3cncn32)cc1","inchiKey":"CLPFFLWZZBQMAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS-16949A","Fadrozole"],"crossReferences":{"Wikipedia":["Fadrozole"]},"childChemblIds":["CHEMBL468419"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL997","canonicalSmiles":"CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"MPBVHIBUJCELCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBANDRONIC ACID","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bondronat","Bonviva","Iasibon","Quodixor"],"synonyms":["Boniva","Ibandronate","Ibandronic Acid","Ibandronic acid"],"crossReferences":{"DailyMed":["ibandronate%20sodium"],"PubChem":["90340689"],"Wikipedia":["Ibandronic_acid"],"drugbank":["DB00710"]},"childChemblIds":["CHEMBL1201008","CHEMBL3989569"],"count":11,"approvedIndications":["EFO_0004260"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0003820","EFO_0001642","MONDO_0007254","EFO_0004260","EFO_0003882","EFO_0003843","EFO_0009708","HP_0000938","EFO_0001422","EFO_0002690","EFO_0003854","MONDO_0008903","EFO_0000764","EFO_0003766","EFO_0001378","MONDO_0024880","EFO_0004259"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for bone disease and has 10 investigational indications."}
